PHA SCR nsp15 endoribonuclease
(Die Seite wurde neu angelegt: „{{up|PHA pharmacophore by screened target}} {{plb|((covid19+OR+covid-19+OR+sars-cov2+OR+sars-cov-2+OR+2019-ncov+OR+2019ncov))+AND+(nsp15+OR+nendou+OR+non-struc…“) |
|||
| (Eine dazwischenliegende Version von einem Benutzer wird nicht angezeigt) | |||
| Zeile 1: | Zeile 1: | ||
{{up|PHA pharmacophore by screened target}} | {{up|PHA pharmacophore by screened target}} | ||
| − | {{plb|((covid19+OR+covid-19+OR+sars-cov2+OR+sars-cov-2+OR+2019-ncov+OR+2019ncov))+AND+(nsp15+OR+nendou+OR+non-structural+protein | + | {{plb|((covid19+OR+covid-19+OR+sars-cov2+OR+sars-cov-2+OR+2019-ncov+OR+2019ncov))+AND+(nsp15+OR+nendou+OR+non-structural+protein+15+OR+endoribonuclease))|nsp15 endoribonuclease }} |
| − | +15+OR+endoribonuclease))|nsp15 endoribonuclease }} | + | |
{{ttp|p=32304108|t=2020. Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2 |pdf=|usr=}} | {{ttp|p=32304108|t=2020. Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2 |pdf=|usr=}} | ||
Aktuelle Version vom 21. April 2021, 20:28 Uhr
| PHA pharmacophore by screened target |
| living current stringent pubmed readout on nsp15 endoribonuclease |
| 32304108 2020. Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2 |
32885740 2020. Identification of promising antiviral drug candidates against non-structural protein 15 (NSP15) from SARS-CoV-2: an in silico assisted drug-repurposing study.
32943302 2020. Identification of phytochemicals as potential therapeutic agents that binds to Nsp15 protein target of coronavirus (SARS-CoV-2) that are capable of inhibiting virus replication.
33155531 2020. Identification and characterization of novel RdRp and Nsp15 inhibitors for SARS-COV2 using computational approach.
33271751 2020. Identification of Persuasive Antiviral Natural Compounds for COVID-19 by Targeting Endoribonuclease NSP15: A Structural-Bioinformatics Approach.
33275961 2020. Drug designing against NSP15 of SARS-COV2 via high throughput computational screening and structural dynamics approach.
C7351674 2020. Structure-based drug designing towards the identification of potential anti-viral for COVID-19 by targeting endoribonuclease NSP15.
| 32188729 2020. Coronavirus Endoribonuclease and Deubiquitinating Interferon Antagonists Differentially Modulate the Host Response during Replication in Macrophages. |
32835632 2020. In silico validation of coumarin derivatives as potential inhibitors against Main Protease, NSP10/NSP16-Methyltransferase, Phosphatase and Endoribonuclease of SARS CoV-2.
